146 related articles for article (PubMed ID: 36439396)
21. Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling.
Mana-Capelli S; McCollum D
J Biol Chem; 2018 Nov; 293(47):18230-18241. PubMed ID: 30266805
[TBL] [Abstract][Full Text] [Related]
22. Role of α-Catenin and its mechanosensing properties in regulating Hippo/YAP-dependent tissue growth.
Sarpal R; Yan V; Kazakova L; Sheppard L; Yu JC; Fernandez-Gonzalez R; Tepass U
PLoS Genet; 2019 Nov; 15(11):e1008454. PubMed ID: 31697683
[TBL] [Abstract][Full Text] [Related]
23. A WT1 co-regulator controls podocyte phenotype by shuttling between adhesion structures and nucleus.
Srichai MB; Konieczkowski M; Padiyar A; Konieczkowski DJ; Mukherjee A; Hayden PS; Kamat S; El-Meanawy MA; Khan S; Mundel P; Lee SB; Bruggeman LA; Schelling JR; Sedor JR
J Biol Chem; 2004 Apr; 279(14):14398-408. PubMed ID: 14736876
[TBL] [Abstract][Full Text] [Related]
24. Wtip and Vangl2 are required for mitotic spindle orientation and cloaca morphogenesis.
Bubenshchikova E; Ichimura K; Fukuyo Y; Powell R; Hsu C; Morrical SO; Sedor JR; Sakai T; Obara T
Biol Open; 2012 Jun; 1(6):588-96. PubMed ID: 23213452
[TBL] [Abstract][Full Text] [Related]
25. Mammalian NDR/LATS protein kinases in hippo tumor suppressor signaling.
Hergovich A; Hemmings BA
Biofactors; 2009; 35(4):338-45. PubMed ID: 19484742
[TBL] [Abstract][Full Text] [Related]
26. Cytoskeletal tension inhibits Hippo signaling through an Ajuba-Warts complex.
Rauskolb C; Sun S; Sun G; Pan Y; Irvine KD
Cell; 2014 Jul; 158(1):143-156. PubMed ID: 24995985
[TBL] [Abstract][Full Text] [Related]
27. LATS tumor suppressor: a new governor of cellular homeostasis.
Visser S; Yang X
Cell Cycle; 2010 Oct; 9(19):3892-903. PubMed ID: 20935475
[TBL] [Abstract][Full Text] [Related]
28. Expression of large tumour suppressor (LATS) kinases modulates chemotherapy response in advanced non-small cell lung cancer.
Luo SY; Kwok HH; Yang PC; Ip MS; Minna JD; Lam DC
Transl Lung Cancer Res; 2020 Apr; 9(2):294-305. PubMed ID: 32420069
[TBL] [Abstract][Full Text] [Related]
29. The scaffold protein Ajuba suppresses CdGAP activity in epithelia to maintain stable cell-cell contacts.
McCormack JJ; Bruche S; Ouadda ABD; Ishii H; Lu H; Garcia-Cattaneo A; Chávez-Olórtegui C; Lamarche-Vane N; Braga VMM
Sci Rep; 2017 Aug; 7(1):9249. PubMed ID: 28835688
[TBL] [Abstract][Full Text] [Related]
30. LIMD1 is a survival prognostic marker of gastric cancer and hinders tumor progression by suppressing activation of YAP1.
Zhang D; Li S; Yu W; Chen C; Liu T; Sun Y; Zhao Z; Liu L
Cancer Manag Res; 2018; 10():4349-4361. PubMed ID: 30349368
[TBL] [Abstract][Full Text] [Related]
31. Recruitment of Jub by α-catenin promotes Yki activity and
Alégot H; Markosian C; Rauskolb C; Yang J; Kirichenko E; Wang YC; Irvine KD
J Cell Sci; 2019 Feb; 132(5):. PubMed ID: 30659113
[TBL] [Abstract][Full Text] [Related]
32. Regulation and functions of mammalian LATS/NDR kinases: looking beyond canonical Hippo signalling.
Hergovich A
Cell Biosci; 2013 Aug; 3(1):32. PubMed ID: 23985307
[TBL] [Abstract][Full Text] [Related]
33. Hsa_circ_0128846 promotes tumorigenesis of colorectal cancer by sponging hsa-miR-1184 and releasing AJUBA and inactivating Hippo/YAP signalling.
Wang X; Chen Y; Liu W; Liu T; Sun D
J Cell Mol Med; 2020 Sep; 24(17):9908-9924. PubMed ID: 32681581
[TBL] [Abstract][Full Text] [Related]
34. Analysis of the Drosophila Ajuba LIM protein defines functions for distinct LIM domains.
Rauskolb C; Han A; Kirichenko E; Ibar C; Irvine KD
PLoS One; 2022; 17(8):e0269208. PubMed ID: 35969522
[TBL] [Abstract][Full Text] [Related]
35. Deubiquitinating Enzyme USP9X Suppresses Tumor Growth via LATS Kinase and Core Components of the Hippo Pathway.
Toloczko A; Guo F; Yuen HF; Wen Q; Wood SA; Ong YS; Chan PY; Shaik AA; Gunaratne J; Dunne MJ; Hong W; Chan SW
Cancer Res; 2017 Sep; 77(18):4921-4933. PubMed ID: 28720576
[TBL] [Abstract][Full Text] [Related]
36. The LIM protein Ajuba is recruited to cadherin-dependent cell junctions through an association with alpha-catenin.
Marie H; Pratt SJ; Betson M; Epple H; Kittler JT; Meek L; Moss SJ; Troyanovsky S; Attwell D; Longmore GD; Braga VM
J Biol Chem; 2003 Jan; 278(2):1220-8. PubMed ID: 12417594
[TBL] [Abstract][Full Text] [Related]
37. Nephrin Suppresses Hippo Signaling through the Adaptor Proteins Nck and WTIP.
Keyvani Chahi A; Martin CE; Jones N
J Biol Chem; 2016 Jun; 291(24):12799-12808. PubMed ID: 27033705
[TBL] [Abstract][Full Text] [Related]
38. The LIM protein, Limd1, regulates AP-1 activation through an interaction with Traf6 to influence osteoclast development.
Feng Y; Zhao H; Luderer HF; Epple H; Faccio R; Ross FP; Teitelbaum SL; Longmore GD
J Biol Chem; 2007 Jan; 282(1):39-48. PubMed ID: 17092936
[TBL] [Abstract][Full Text] [Related]
39. The characterisation of LATS2 kinase regulation in Hippo-YAP signalling.
Hoa L; Kulaberoglu Y; Gundogdu R; Cook D; Mavis M; Gomez M; Gomez V; Hergovich A
Cell Signal; 2016 May; 28(5):488-497. PubMed ID: 26898830
[TBL] [Abstract][Full Text] [Related]
40. LIMD1 antagonizes E2F1 activity and cell cycle progression by enhancing Rb function in cancer cells.
Mayank AK; Sharma S; Deshwal RK; Lal SK
Cell Biol Int; 2014 Jul; 38(7):809-17. PubMed ID: 24523249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
